ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

About ASN

Daniel E. Weiner, MD, MS, FASN, Councilor

ASN Biography
Dan is a nephrologist at Tufts Medical Center, Associate Professor of Medicine at Tufts University School of Medicine, and a medical director at DCI Boston. He is the Medical Director of Clinical Research for Dialysis Clinic, Inc. and Editor-in-Chief of Kidney Medicine and of the Primer on Kidney Diseases, 8th edition. He is the ASN's representative to Kidney Care Partners and a member of ASN's Quality Committee and ASN's Policy and Advocacy Committee. His research interests include dialysis, CKD and hypertension. He is willing at any time to provide detailed opinions on the Celtics, Red Sox and Patriots.

Current Position/Titles:

  • Associate Professor of Medicine, Tufts University School of Medicine
  • Director of Dialysis, Tufts Medical Center
  • Director of Research, Division of Nephrology, Tufts Medical Center
  • Medical Director, DCI Boston
  • Degrees/Training:

  • B.A., Tufts University, Medford, MA; 1994
  • M.D., Tufts University School of Medicine, Boston, MA; 1998
  • M.S., Clinical Care Research, Tufts University Graduate School of Biomedical Sciences; 2004
  • Internal Medicine Residency: University of Maryland
  • Chief Resident: University of Maryland
  • Nephrology Fellowship: Tufts Medical Center
  • ASN Service:

    Member, American Society of Nephrology Dialysis Advisory Group, 2010-2013; Member, American Society of Nephrology ACO Task Force, Writing Group, 2011-2012; Member, American Society of Nephrology Quality & Safety Work Group, 2011-2012; Member, ASN Quality Metrics Task Force, 2012-2013; Chair, ASN Quality Metrics Task Force, 2013-2016; Member, ASN Public Policy Board, 2014-2016; ASN Representative, Kidney Care Partners, 2015-present; Member, ASN Policy and Advocacy Committee, 2016-present; Chair, ASN Quality Committee, 2016-2018; Member, ASN Quality Committee, 2019-present; Abstract Selection Committee Member, multiple years; Chair, Abstract Selection Committee for CKD Complications, 2012; Chair, Abstract Selection Committee for CKD: Cognition, Depression and Quality of Life, 2015.

    Leadership positions:

    Editor-in-Chief, Kidney Medicine, 2018-present; Deputy Editor, American Journal of Kidney Diseases, 2006-2016; Co-Editor-in-Chief, Primer on Kidney Diseases, 6th, 7th, and 8th editions; Medical Director of Clinical Research, Dialysis Clinic, Inc.; Chair, Tufts University School of Medicine Curriculum Committee, 2012-2015; Chair, Program Committee, 2016 National Kidney Foundation Spring Clinical Meetings, 2016; Member, National Kidney Foundation Scientific Advisory Board, 2021-present; Chair, ESRD Physician Level Measure Development Technical Expert Panel, 2018; Chair, NKF KDOQI Patient-Centered Quality Measures for Dialysis Care Workshop, 2022


    American Society of Nephrology Distinguished Leader Award, 2019; National Kidney Foundation J Michael Lazarus Award, 2022; Boston's Best Doctors, 2016-present

    Board Certification:

    ABIM Nephrology and Internal Medicine

    Research Interests:

    I have broad, collaborative research interests, all of which are inspired by the patients and families I work with every day. My focus areas include dialysis epidemiology, with extensive work on the impacts of COVID-19 on the dialysis community. Additionally, I am a principal investigator on a PCORI-funded study evaluation decision-making in older adults with advanced CKD. I am involved in clinical trials and have evaluated the intersection of CKD, cardiovascular disease, cerebrovascular disease and cognitive impairment. Lastly, I have published extensively on kidney policy, positioning me well to be a strong contributor to ASN Council.

    Personal Statement:

    I consider myself a clinician first, and everything else I do - in research, teaching or advocacy - is with the goal of helping the person in front of me or helping the next person confronting similar challenges. In 2016, I was thrilled to be selected as the inaugural chair of ASN's Quality Committee, and, in this role, I was privileged to work with exceptionally talented people to help conceptualize kidney policy. Moving forward, the kidney community faces many challenges including workforce issues, insufficient innovation, and inadequate research funding. As a member of ASN Council, I will continue my service to the kidney community, advocating vigorously to address these issues in order to improve care for all people with kidney disease and at risk for kidney diseases.